Skip to main content Accessibility help
×
Home
  • Print publication year: 2009
  • Online publication date: May 2010

Section 2 - Etiology of non-traumatic intracerebral hemorrhage

References

1. Jüttler E, Steiner T. Treatment and prevention of spontaneous intracerebral hemorrhage: comparison of EUSI and AHA/ASA recommendations. Expert Rev Neurother 2007; 7(10): 1401–16. Review.
2. Ayala C, Croft JB, Greenlund KJ, et al. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995–1998. Stroke 2002; 33(5): 1197–1201.
3. Weimar C, Weber C, Wagner M, et al. Management patterns and health care use after intracerebral hemorrhage. A cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis 2003; 15: 29–36.
4. Labovitz DL, Halim A, Boden-Albala B, et al. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology 2005; 65(4): 518–522.
5. Jiang B, Wang WZ, Chen H, et al. Incidence and trend of stroke and its subtypes in China: results from three large cities. Stroke 2006; 37(1): 63–68.
6. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344(19): 1450–1460.
7. Ariesen MJ, Claus SP, Rinkel GJ, et al. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 2003; 34(8): 2060–2065.
8. Kurth T, Kase CS, Berger K, et al. Smoking and the risk of hemorrhagic stroke in men. Stroke 2003; 34: 1151–1155.
9. Kurth T, Kase CS, Berger K, et al. Smoking and risk of hemorrhagic stroke in women. Stroke 2003; 34: 2792–2795.
10. Iso H, Baba S, Mannami T, et al. Alcohol consumption and risk of stroke among middle-aged men: the JPHC Study Cohort I. Stroke 2004; 35: 1124–1129.
11. Thrift AG, Donnan GA, McNeil JJ. Heavy drinking, but not moderate or intermediate drinking, increases the risk of intracerebral hemorrhage. Epidemiology 1999; 10: 307–312.
12. Feldmann E, Broderick JP, Kernan WN, et al. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke 2005; 36: 1881–1885.
13. Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group. Ann Epidemiol 1993; 3: 493–499.
14. Iribarren C, Jacobs DR, Sadler M, Claxton AJ, Sidney S. Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program. Stroke 1996; 27: 1993–1998.
15. Suh I, Jee SH, Kim HC, et al. Low serum cholesterol and haemorrhagic stroke in men: Korea Medical Insurance Corporation Study. Lancet 2001; 357: 922–925.
16. Vermeer SE, Algra A, Franke CL, Koudstaal PJ, Rinkel GJ. Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology 2002; 59: 205–209.
17. Ferro JM. Update on intracerebral haemorrhage. J Neurol 2006; 253(8): 985–999. Epub 2006 May 6. Review.
18. Kase CS, Mohr JP, Caplan LR. Intracerebral hemorrhage. In: Mohr JP, Choi DC, Grotta JC, et al., eds. Stroke: Pathophysiology, Diagnosis and Management, 4th edn. Philadelphia, Churchill Livingstone. 2004; 327–376.
19. Caplan LR. Intracerebral hemorrhage. In: Caplan LR, ed. Caplan's Stroke: A Clinical Approach, 3rd edn. Boston, Butterworth-Heinemann. 2000; 383–418.
20. Broderick JP, Brott T, Tomsick T, Huster G, Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared to whites. N Engl J Med 1992; 326(11): 733–736.
21. Sacco RL, Boden-Albala B, Gan R, et al. Stroke incidence among white, black and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998; 147: 259–268.
22. Bruno A, Carter S. Possible reason for the higher incidence of spontaneous intracerebral hemorrhage among Hispanics than non-Hispanic whites in New Mexico. Neuroepidemiology 2000; 19: 51–52.
23. Ayala C, Greenlund KJ, Croft JB, et al. Racial/ethnic disparities in mortality by stroke subtype in the United States, 1995–1998. Am J Epidemiol 2001; 154: 1057–1063.
24. Smeeton NC, Heuschmann PU, Rudd AG, et al. Incidence of hemorrhagic stroke in black Caribbean, black African, and white populations: the South London stroke register, 1995–2004. Stroke 2007; 38(12): 3133–3138. Epub 2007 Oct 25.
25. Petitti DB, Sidney S, Bernstein A, et al. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996; 335: 8–15.
26. Qureshi AI, Giles WH, Croft JB. Racial differences in the incidence of intracerebral hemorrhage: effects of blood pressure and education. Neurology 1999; 52: 1617–1621.
27. Flaherty ML, Woo D, Haverbusch M, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke 2005; 36: 934–937.
28. Song YM, Sung J, Lawlor DA, et al. Blood pressure, haemorrhagic stroke, and ischaemic stroke: the Korean national prospective occupational cohort study. BMJ 2004; 328: 324–325.
29. Woo D, Haverbusch M, Sekar P, et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke 2004; 35: 1703–1708.
30. Perry HM Jr, Davis BR, Price TR, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000; 284: 465–471.
31. Marietta M, Pedrazzi P, Girardis M, Torelli G. Intracerebral haemorrhage: an often neglected medical emergency. Intern Emerg Med 2007; 2(1): 38–45. Epub 2007 Mar 31. Review.
32. Pleşea IE, Cameniţă A, Georgescu CC, et al. Study of cerebral vascular structures in hypertensive intracerebral haemorrhage. Rom J Morphol Embryol 2005; 46(3): 249–256.
33. Sutherland GR, Auer RN. Primary intracerebral hemorrhage J Clin Neurosci 2006; 13(5): 511–517.
34. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007; 130(Pt 8): 1988–2003. Epub 2007 Feb 24.
35. Lee SH, Park JM, Kwon SJ, et al. Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients. Neurology 2004; 63: 16–21.
36. Lee SH, Kwon SJ, Kim KS, Yoon BW, Roh JK. Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area. J Neurol 2004; 251: 1183–1189.
37. Laissy JP, Normand G, Monroc M, et al. Spontaneous intracerebral hematomas from vascular causes. Neuroradiology 1991; 33: 291–295.
38. Watanabe A. Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. J Stroke Cerebrovasc Dis 2007; 16(1): 30–33.
39. Tanaka A, Ueno Y, Nakayama Y, et al. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke 1999; 30: 1637–1642.
40. Roob G, Fazekas F. Magnetic resonance imaging of cerebral microbleeds. Curr Opin Neurol 2000; 13: 69–73.
41. Roob G, Lechner A, Schmidt R, et al. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke 2000; 31: 2665–2669.
42. Roob G, Schmidt R, Kapeller P, et al. MRI evidence of past cerebral microbleeds in a healthy elderly population, Neurology 1999; 52: 991–994.
43. Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981; 246: 2177–2180.
44. Harper G, Castleden CM, Potter JF. Factors affecting changes in blood pressure after acute stroke. Stroke 1994; 25: 1726–1729.
45. Fogelholm R, Avikainen S, Murros K. Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 1997; 28: 1396–1400.
46. Portenoy RK, Lipton RB, Berger AR, Lesser ML, Lantos G. Intracerebral haemorrhage: a model for the prediction of outcome. J Neurol Neurosurg Psychiatry 1987; 50: 976–979.
47. Tuhrim S, Dambrosia JM, Price TR, et al. Prediction of intracerebral hemorrhage survival. Ann Neurol 1988; 24: 258–263.
48. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987–993.
49. Carlberg B, Asplund K, Hagg E. The prognostic value of admission blood pressure in patients with acute stroke. Stroke 1993; 24: 1372–1375.
50. Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995; 26(1): 21–24.
51. Leira R, Dávalos A, Silva Y, et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 2004; 63: 461–467.
52. Qureshi AI, Safdar K, Weil J, et al. Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke 1995; 26(10): 1764–1767.
53. Terayama Y, Tanahashi N, Fukuuchi Y, Gotoh F. Prognostic value of admission blood pressure in patients with intracerebral hemorrhage: Keio cooperative stroke study. Stroke 1997; 28: 1185–1188.
54. Dunne JW, Chakera T, Kermode S. Cerebellar haemorrhage–diagnosis and treatment: a study of 75 consecutive cases. QJM 1987; 64: 739–754.
55. Meyer JS, Bauer RB. Medical treatment of spontaneous intracranial hemorrhage by the use of hypotensive drugs. Neurology 1962; 12: 36–47.
56. Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial haemorrhage – part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006; 22(4): 294–316. Epub 2006 Jul 28. Erratum in: Cerebrovasc Dis 2006; 22(5–6): 461. Katse, Markku [corrected to Kaste, Markku].
57. Tietjen CS, Hurn PD, Ulatowski JA, et al. Treatment modalities for hypertensive patients with intracranial pathology: options and risks. Crit Care Med 1996; 24: 311–322.
58. Chillon J-M, Baumbach GI. Autoregulation: arterial and intracranial pressure. In: Edvinsson L, Krause DN, eds. Cerebral Blood Flow and Metabolism, 2nd edn. Philadelphia, Lippincott Williams & Wilkins. 2002; 395–412.
59. Morgenstern LB. Medical therapy of intracerebral and intraventricular hemorrhage. In: Mohr JP, Choi DC, Grotta JC, et al., eds. Stroke: Pathophysiology, Diagnosis and Management, 4th edn. Philadelphia, Churchill Livingstone. 2004; 1079–1087.
60. Qureshi AI, Bliwise DL, Bliwise NG, et al. Rate of 24-h blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med 1999; 27: 480–485.
61. Qureshi AI, Mohammad YM, Yahia AM, et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med 2005; 20: 34–42.
62. Broderick J, Connolly S, Feldmann E, et al. American Heart Association/American Stroke Association Stroke Council; American Heart Association/American Stroke Association High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working Group. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007; 116(16): e391–413. Republished from: Stroke 2007; 38(6): 2001–2023.
63. Vespa P. What is the optimal threshold for cerebral perfusion pressure following traumatic brain injury? Neurosurg Focus 2003; 15: E4. Review.
64. Robertson CS, Valadka AB, Hannay HJ, et al. Prevention of secondary ischemic insults after severe head injury. Crit Care Med 1999; 27: 2086–2095.
65. Chambers IR, Banister K, Mendelow AD. Intracranial pressure within a developing intracerebral haemorrhage. Br J Neurosurg 2001; 15: 140–141.
66. Fernandes HM, Siddique S, Banister K, et al. Continuous monitoring of ICP and CPP following ICH and its relationship to clinical, radiological and surgical parameters. Acta Neurochir Suppl. 2000; 76: 463–466.
67. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997; 28: 2370–2375.
68. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998; 29: 1160–1166.
69. Qureshi AI, Wilson DA, Hanley DF, Traystman RJ. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage. Crit Care Med 1999; 27: 965–971.
70. Ohwaki K, Yono E, Nagashima H, et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004; 35(6): 1364–1367.
71. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage: incidence and time course. Stroke 1996; 27: 1783–1787.
72. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28(1): 1–5.
73. Broderick JP, Diringer MN, Hill MD, et al. Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 2007; 38(3): 1072–1075.
74. Jauch EC, Lindsell CJ, Adeoye O, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke 2006; 37: 2061–2065.
75. Adams RE, Powers WJ. Management of hypertension in acute intracerebral hemorrhage. Crit Care Clin 1997; 13(1): 131–161.
76. Herweh C, Juttler E, Schellinger, PD et al. Evidence against a perihemorrhagic penumbra provided by perfusion CT. Stroke 2007; 38(11): 2941–2947.
77. Zhao X, Wang Y, Wang C, et al. Quantitative evaluation for secondary injury to perihematoma of hypertensive cerebral hemorrhage by functional MR and correlation analysis with ischemic factors. Neurol Res 2006; 28(1): 66–70.
78. Siddique MS, Fernandes HM, Wooldridge TD, et al. Reversible ischemia around intracerebral hemorrhage: a single-photon emission computerized tomography study. J Neurosurg 2002\; 96(4): 736–741.
79. Rosand J, Eskey C, Yuchiao C, et al. Dynamic single-section CT demonstrates reduced cerebral blood flow in acute intracerebral hemorrhage. Cerebrovasc Dis 2002; 14(3–4): 214–220.
80. Fainardi E, Borrelli M, Saletti A, et al. Assessment of acute spontaneous intracerebral hematoma by CT perfusion imaging. J Neuroradiol 2005; 32(5): 333–336.
81. Butcher KS, Baird T, MacGregor L, et al. Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke 2004; 35(8): 1879–1885.
82. Schellinger PD, Fiebach JB, Hoffmann K, et al. Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke 2003; 34(7): 1674–1679.
83. Kidwell CS, Saver JL, Mattiello J, et al. Diffusion–perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology 2001; 57(11): 1611–1617.
84. Zazulia AR, Diringer MN, Videen TO, et al. Hypoperfusion without ischemia surrounding intracerebral hemorrhage. J Cereb Blood Flow Metab 2001; 21(7): 804–810.
85. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6–22 h) intracerebral hemorrhage. Neurology 2001; 57(1): 18–24.
86. Becker KJ, Baxter AB, Bybee HM, et al. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke 1999; 30(10): 2025–2032.
87. Gebel JM Jr, Jauch EC, Brott TG, et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002; 33: 2631–2635.
88. Gebel JM Jr, Jauch EC, Brott TG, et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002; 33: 2636–2641.
89. Asdaghi N, Manawadu D, Butcher K. Therapeutic management of acute intracerebral haemorrhage. Expert Opin Pharmacother 2007; 8(18): 3097–3116. Review.
90. Bereczki D, Liu M, Prado GF, Fekete I. Cochrane report: a systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke 2000; 31(11): 2719–2722.
91.Interventions for deliberately altering blood pressure in acute stroke. Blood Pressure in Acute Stroke Collaboration (BASC). Cochrane Database Syst Rev 2000; (2): CD000039.
92. Clarke B, Grant D, Patmore L. Comparative calcium entry blocking properties of nicardipine, nifedipine and PY-108–68 on cardiac and vascular smooth muscle. Br J Pharmacol 1983; 79: 333P.
93. Fischell TA, Maheshwari A. Current applications for nicardipine in invasive and interventional cardiology. J Invasive Cardiol 2004; 16(8): 428–432.
94. Alps BJ, Hass WK. The potential beneficial effect of nicardipine in a rat model of transient forebrain ischemia. Neurology 1987; 37: 809–814.
95. Nakaya H, Kanno M. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs. Arzneimittel-Forschung 1982; 32: 626–629.
96. Michel AD, Whiting RL. Cellular action of nicardipine. Am J Cardiol 1989; 64: 3H–7H.
97. Cardene IV [package insert]. Edison, NJ: ESP Pharma, Inc.: 2003.
98. Qureshi AI, Harris-Lane P, Kirmani JF, et al. Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med 2006; 34(7): 1975–1980.
99. Sorimachi T, Fujii Y, Morita K, Tanaka R. Predictors of hematoma enlargement in patients with intracerebral hemorrhage treated with rapid administration of antifibrinolytic agents and strict blood pressure control. J Neurosurg 2007; 106(2): 250–254.
100. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest 2000; 118(1): 214–227.
101. Broderick JP, Adams HP Jr, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30: 905–915.
102. Patel RV, Kertland HR, Jahns BE, et al. Labetalol: response and safety in critically ill hemorrhagic stroke patients. Ann Pharmacother 1993; 27(2): 180–181.
103. Butterworth RJ, Cluckie A, Jackson SH, Buxton-Thomas M, Bath PM. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 1998; 8(3): 158–165.
104. Bae H, Jeong D, Doh J, et al. Recurrence of bleeding in patients with hypertensive intracerebral hemorrhage. Cerebrovasc Dis 1999; 9(2): 102–108.
105. Chen CH, Huang CW, Chen HH, et al. Recurrent hypertensive intracerebral hemorrhage among Taiwanese. Kaohsiung J Med Sci 2001; 17(11): 556–563.
106. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003; 34: 2741–2748.
107. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6, 105 individuals with previous stroke or transient ischemic attack. Lancet 2001; 358(9287): 1033–1041.
108. Qureshi AI. Antihypertensive treatment of acute cerebral hemorrhage (ATACH): rationale and design. Neurocrit Care 2007; 6(1): 56–66.
109. Qureshi, A I. “ATACH: Antihypertensive Treatment in Acute Cerebral Hemorrhage.” www.strokecenter.org. 27 Feb. 2006. UMDNJ, Newark NJ. 3 Jan. 2008 http://www.strokecenter.org/trials/TrialDetail.aspx?tid=602.
110. Anderson C and Neal B. “Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage.” ClinicalTrial.Gov. 4 Jan. 2008. The George Institute, National Health and Medical Research Council, Australia. 5 Jan. 2008 http://www.clinicaltrials.gov/ct/show/NCT00226096?order=1.
111. Anderson C. “INTERACT-Pilot: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage – Pilot Study.” Strokecenter.Org. 20 Mar. 2007. Royal Prince Alfred Hospital, Australia. 3 Jan. 2008 http://strokecenter.org/trials/TrialDetail.aspx?tid=569.
112. Butcher K. “ICH ADAPT: Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial.” Strokecenter.Org. 10 May 2007. Health Sciences Centre, Division of Neurology, Canada. 3 Jan. 2008 http://strokecenter.org/trials/TrialDetail.aspx?tid=748.
113. Butcher K. “ICH-ADAPT-E: Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial – Extended.” Strokecenter.Org. 10 May 2007. Health Sciences Centre, Division of Neurology, Canada. 3 Jan. 2008 http://strokecenter.org/trials/TrialDetail.aspx?tid=722.
114. Wang DZ. “CARING: Nicardipine for the Treatment of Hypertension in Patients with Ischemic Stroke, Intracerebral Hemorrhage or Subarachnoid Hemorrhage.” Strokecenter.Org. 25 Apr. 2007. St. Francis Medical Center, IL. 3 Jan. 2008 http://strokecenter.org/trials/TrialDetail.aspx/tid/600.